Skip to main content

and
  1. No Access

    Article

    Pharmacokinetics and metabolism of the staurosporine analogue CGP 41 251 in mice

    Studies with CGP 41 251 (I), an N-benzoylstaurosporine derivative and PKC-α inhibitor, revealed that oral administration of 400 μg/day of the compound to wild type mice on four successive days reversed multi d...

    R. van Gijn, O. van Tellingen, E. Haverkate in Investigational New Drugs (1999)